Latest Regulatory Approvals News

Tamboran Resources is set to acquire Falcon Oil & Gas Ltd., consolidating a dominant position in the Beetaloo Basin with nearly 3 million net prospective acres. The deal, valued at US$172 million, positions Tamboran as a leading Australian E&P player ahead of key development phases.

Tamboran Resources is set to acquire Falcon Oil & Gas, creating a dominant player with approximately 2.9 million net prospective acres in Australia's Beetaloo Basin. The deal, valued at over US$500 million pro forma, aims to strengthen Tamboran's development footprint and shareholder base.

Aguia Resources has announced a one-for-ten entitlement issue to raise up to $4 million, including free attaching options, aimed at advancing its Santa Barbara Gold Project and supporting working capital.

Nova Eye Medical has gained regulatory approval for its iTrack Advance glaucoma device in China, setting the stage for significant market expansion and sales growth from late fiscal 2026.

Syntara Limited has reported positive final data from its Phase 2a trial of amsulostat in myelofibrosis, demonstrating significant symptom relief and spleen volume reduction with a favorable safety profile. These results pave the way for advancing clinical development and partnership discussions.

Orthocell has appointed its first Canadian distributor for Remplir, its innovative nerve repair device, ahead of an official launch at a major surgical conference in Vancouver. The move marks a significant step in expanding the product’s international footprint.

Australian Vanadium Limited has locked in a US$10 million secured loan from major shareholder RCF to advance its flagship vanadium project and prepare for a significant government battery storage tender.

Southern Cross Media Group and Seven West Media have agreed to merge in an all-scrip deal, creating a dominant integrated TV, audio, and digital platform across Australia. The merger aims to unlock significant cost synergies and expand audience reach across metropolitan and regional markets.

Seven West Media and Southern Cross Media have announced a proposed all-scrip merger to create a leading integrated media company spanning TV, audio, digital, and publishing platforms across Australia.

Southern Cross Media Group and Seven West Media have agreed to merge, creating a dominant integrated TV, audio, and digital platform in Australia. The deal promises significant cost synergies and shareholder value accretion, pending regulatory and shareholder approvals.

Seven West Media and Southern Cross Media have agreed to merge, creating a dominant integrated media company with extensive reach across TV, audio, and digital platforms in Australia. The merger promises significant cost synergies and enhanced shareholder value, pending regulatory and shareholder approvals.

Dimerix Limited’s lead drug candidate DMX-200 has been granted Orphan Drug Designation in Japan for treating Focal Segmental Glomerulosclerosis (FSGS), enhancing its regulatory and commercial prospects in a key market.